Derlis Christian Fleitas Sosa, MD

Todd Metz graduated from Walsh University with a bachelor's degree in Pre-Med/Biology in 2003. Through their accelerated program, he earned his Bachelor of Science in Nursing in 2007 from the University of Akron. After graduation, he moved to Charleston, South Carolina, and worked as an R.N. at Roper Hospital in the Surgical Intensive Care Unit. He graduated from MUSC's College of Nursing with a Master's in Nursing in Family Nurse Practitioner degree in 2013. He remained at Roper Hospital in the SICU as a Nurse Practitioner and became the Supervisor of the Advanced Practice Providers (APPs) at Roper Hospital. As the lead APP for the Intensivist Services, he supervised 13 other APPs at both Roper Hospital in the SICU and CVICU, as well as the ICU at Bon Secours St. Francis Hospital, and continued to lead them for seven years. More recently, he accepted the position as bedside APP for the Department of Anesthesia in the MSICU and will start this summer.

Dr. Michelle Hudspeth is a 1999 graduate of the MUSC College of Medicine and completed her residency, chief residency, and fellowship at the Johns Hopkins Hospital and the National Cancer Institute. She is the division chief for pediatric hematology/oncology and is the director of the pediatric blood and marrow transplant program and the quality director for the combined adult and pediatric blood and marrow transplant program. Her main clinical focus is transplantation, including haploidentical, related and unrelated allogeneic, cord blood, and autologous donor sources. She is the institutional principal investigator for Pediatric Blood and Marrow Transplant Consortium trials. She is a member of the Pediatric Blood and Marrow Transplant Consortium GVHD committee and supportive care committee. She also serves on several working committees (GVHD, pediatric cancer, immune deficiencies/inborn errors of metabolism) for the Center for International Blood and Marrow Transplant Research. Her clinical research includes multiple aspects of transplantation, including a clinical trial incorporating pravastatin for matched related donor transplants for sickle cell disease.